Skip to main content

Table 2 Baseline variables according to with or without GBPs after follow-up

From: Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study

Variable

Without GBPs after fellow-up (n = 1729)

With GBPs after follow-up (n = 137)

P-value

Age (yr)

48.91 ± 13.79

48.20 ± 11.13

0.56

BMI (kg/m2)

24.54 ± 2.95

24.98 ± 2.70

0.107

ALT (U/L)

32.77 ± 37.73

32.07 ± 20.34

0.319

AST (U/L)

25.98 ± 18.96

25.64 ± 17.92

0.33

GGT (U/L)

40.14 ± 39.12

42.86 ± 48.20

0.178

ALP (U/L)

76.12 ± 18.97

76.73 ± 18.11

0.714

TG (mmol/l)

1.85 ± 1.58

2.14 ± 2.10

0.028

LDL-c (mmol/l)

2.70 ± 0.69

2.77 ± 0.74

0.232

TC (mmol/l)

4.89 ± 0.83

4.99 ± 0.86

0.186

HDL-c (mmol/l)

1.37 ± 0.26

1.33 ± 0.25

0.094

Non-HDL-c (mmol/l)

3.52 ± 0.80

3.66 ± 0.81

0.056

Non-HDL-c/HDL-c ratio

2.65 ± 0.77

2.82 ± 0.76

0.016

UA (μmol/L)

381.59 ± 73.19

382.65 ± 67.36

0.869

FPG (mmol/l)

5.32 ± 1.24

5.36 ± 1.45

0.703

HBsAg, n (%)

143 (8.27%)

13 (9.49%)

0.62

Hypertension, n (%)

400 (23.13%)

30 (21.90%)

0.741

TGW, n (%)

5 (0.29%)

0 (0.00%)

0.529

Smoking, n (%)

145 (8.43%)

14 (10.29%)

0.453

Drinking, n (%)

66 (3.83%)

7 (5.15%)

0.448

  1. Data expressed as mean ± SD or percentage
  2. GBPs gallbladder polyps; BMI, body mass index, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT gamma-glutamyl transpeptidase, ALP alkaline phosphatase, TG triglyceride, LDL-c low-density lipoprotein-cholesterol, TC total cholesterol, HDL-c high-density lipoprotein –cholesterol, UA uric acid, FPG fasting plasma glucose, HBsAg hepatitis B surface antigen, TGW thickening of the gallbladder wall